Table 3.
Penetration of the platinum analogs into the CNS (CSF standard sampling or brain measured using microdialysis) expressed as a percentage of drug systemic exposure (AUC in plasma UF by standard sampling or vein by microdialysis)
| CSF:Plasma UF | Brain:Vein | |
|---|---|---|
| Cisplatin | 4.4, 5.4a | 1.0, 3.1a |
| Carboplatin | 1.5 (1.4–5.0) | 3.1 (3.0–3.1) |
| Oxaliplatin | 0.3 (0.3–0.8) | 2.2 (1.4–8.0) |
Values represent the median (range)
Data from two animals receiving the 10 mg/kg dose